Abstract:Background Excessive generation of reactive oxygen species (ROS) in the presence of a defective antioxidant system can induce cellular damage and disrupt normal physiological functions. Several studies have revealed the unfavorable role of ROS in promoting the growth, proliferation, migration, and survival of leukemia cells. In this review study, we summarize the mechanisms of ROS production and its role in leukemogenesis, counteractive effects of antioxidants, and implicate the current ROS-dependent anticancer therapies in acute myeloid leukemia. Body The dysregulation of the redox system is known to play a significant role in the pathogenesis of leukemia. Leukemia cells generate high levels of ROS, which further increases the levels through extra pathways, including mitochondrial deoxyribonucleic mutation, leukemic oncogene activation, increased nicotinamide adenine phosphate hydrogen (NADPH), and cytochrome P450 activities. Aforementioned pathways once activated have shown to promote genomic instability, induce drug resistance to leukemia medical therapy, disease relapse and reduce survival period. The current standard of treatment with chemotherapy employs the pro-oxidant approach to induce apoptosis and promote tumor regression. However, this approach retains several deleterious effects on the subject resulting in degradation of the quality of life. Nevertheless, the addition of an antioxidant as an adjuvant drug to chemotherapy alleviates treatment-related toxicity, increases chemotherapeutic efficacy, and improves survival rates of a patient. Conclusion Acute myeloid leukemia remains a daunting challenge to clinicians. The desire to achieve the maximum benefit of chemotherapy but also improve patient outcomes is investigated. ROS generated through several pathways promotes leukemogenesis, drug resistance, and disease relapse. Chemotherapy, the mainstay of treatment, further upregulates ROS levels. Therefore, the addition of an antioxidant to leukemia medical therapy alleviates toxicity and improves patient outcomes.

Oxidative Stress Response Induced by Chemotherapy in Leukemia Treatment (Review)

Oxidative stress in leukemia and antioxidant treatment

The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications

Oxidative stress is two-sided in the treatment of acute myeloid leukemia

Oxidative stress in normal hematopoietic stem cells and leukemia

Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.

Drug-induced oxidative stress in cancer treatments: Angel or devil?

Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects

Antioxidant Therapy in Cancer: Rationale and Progress

Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications

The role of cellular reactive oxygen species in cancer chemotherapy

Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?

Oxidative Stress in Cancer Therapy: Friend or Enemy?

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy

The Cancer Antioxidant Regulation System in Therapeutic Resistance

Oxidative Stress Targeted Therapies for the Treatment of Acute Myeloid Leukemia

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Survey on the Oxidative Stress Status and the Role of Antioxidants in Acute Myeloid Leukemia Therapy

The Role of Oxidative Stress in Tumorigenesis and Progression

Oxidative Stress in Cancer Cell Metabolism